Triazole Resistance in Aspergillus fumigatus Clinical Isolates Obtained in Nanjing, China
@inproceedings{Zhang2017TriazoleRI, title={Triazole Resistance in Aspergillus fumigatus Clinical Isolates Obtained in Nanjing, China}, author={Ming Zhang and Chun-lai Feng and Fei Chen and Qian He and Xin Su and Yi Shi}, booktitle={Chinese medical journal}, year={2017} }
BACKGROUND
During the past decades, the incidence of invasive aspergillosis (IA) caused by Aspergillus fumigatus has increased dramatically. The aims of this study were to investigate the susceptibility of clinical isolates of A. fumigatus to triazole and the underlying cyp51A mutations in triazole-resistant A. fumigatus.
METHODS
A total of 126 A. fumigatus clinical isolates from 126 patients with proven or probable IA were obtained from four large tertiary hospitals in Nanjing, China… CONTINUE READING
Citations
Publications citing this paper.
SHOWING 1-2 OF 2 CITATIONS
Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet Bioavailability
VIEW 8 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED
References
Publications referenced by this paper.
SHOWING 1-10 OF 19 REFERENCES
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL
Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007-2009
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL
Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL
cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL